mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.01 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |